Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 10-Q Report Quarterly Report
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Results of operations
  7. 4 Derivatives Options or other derivatives
  8. DEFA14A Proxy Proxy Materials
  9. DEF 14A Proxy Proxy Statement
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. 424B5 Offering Prospectus
  14. 8-K Event Material agreement · Other events
  15. 424B5 Offering Prospectus
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. 8-K Event Other events
  19. SC 13G Stake Amended Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 43 of 77 · 1,525 filings